Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
227.17
+0.07 (0.03%)
Nov 4, 2024, 4:00 PM EST - Market closed

Labcorp Holdings Operating Income by Segment

History

Date Diagnostics Drug Development General Corporate Expenses
Sep 30, 20241.60B437.20M-269.00M
Jun 30, 20241.60B425.30M-273.20M
Mar 31, 20241.57B422.50M-382.10M
Dec 31, 20231.59B446.50M-389.00M
Sep 30, 20231.62B546.00M-406.80M
Jun 30, 20231.68B647.70M-396.80M
Mar 31, 20231.78B756.40M-291.70M
Dec 31, 20222.03B801.10M-277.50M
Sep 30, 20222.41B798.30M-276.80M
Jun 30, 20222.75B813.70M-309.30M
Mar 31, 20222.90B821.50M-280.90M
Dec 31, 20213.21B887.00M-267.00M
Sep 30, 20213.66B929.70M-235.40M
Jun 30, 20213.89B913.30M-199.30M
Mar 31, 20213.54B804.90M-195.70M
Dec 31, 20202.80B721.60M-191.00M
Sep 30, 20201.84B656.40M-176.00M
Jun 30, 20201.14B621.70M-159.00M
Mar 31, 20201.17B650.70M-158.40M
Dec 31, 20191.23B637.90M-156.30M
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.